EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS

Show other versions (1)

The article presents the results of a study of effectiveness and safety of infliximab — monoclonal antibodies to tumor necrotizing factor (TNF) _ in treatment of 47 patients in age 11 months — 16 years old with early pauciarticular and polyarticular types of juvenile rheumatoid arthritis. The durati...

Full description

Bibliographic Details
Main Authors: E.I. Alexeeva, T.V. Sleptsova, S.I. Valieva, T.M. Bzarova, R.V. Denisova, A.O. Lisitsin, E.Yu. Gudkova, A.M. Chomakhidze, K.B. Isaeva, A.A. Grigor’eva, O.L. Lomakina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2009-07-01
Series:Voprosy Sovremennoj Pediatrii
Online Access:https://vsp.spr-journal.ru/jour/article/view/1142

Internet

https://vsp.spr-journal.ru/jour/article/view/1142

Similar Items